04.01.2022 • NewsInvista

Invista Wins China Nylon Licensing Contract

Invista Textiles (UK), a division of US nylon giant Invista, has signed an agreement with China Resources Yantai Nylon to license technology for a new plant in China. The companies did not disclose a timeframe for the project.

Under the terms of the deal, Invista will supply its proprietary nylon 6,6 polymerization process for a facility located in the Economy & Technology Developing Zone in Yantai City, Shandong province. Invista said the line is the first since 2015 to license the technology.

“As with China Resources and all local partners, we look forward to working closely together for success on this new project and to identify additional opportunities for nylon 6,6 downstream applications, enabling strong growth as we contribute to the upgrading of the nylon 6,6 industry in China,” said Pete Brown, nylon polymer executive vice president, global intermediates, Invista.

Separately, Invista has taken over Flint Hills Resources’ propylene business with effect from Jan. 1. The transaction includes the plants in Houston and Longview, Texas. Ownership of the pipelines that supply these facilities will also transfer to Invista, but they will continue to be operated by Flint Hills Resources under contract.

“We’re excited for the opportunities that will be made possible by this integration of two of Koch Industries’ chemicals businesses,” said Invista chairman and CEO Jeff Gentry. “Flint Hills Resources’ propylene business complements Invista’s portfolio and will help us accelerate our vision of building a leading polymers and advanced materials company.”

Author: Dede Williams, Freelance Journalist

(c) Invista
(c) Invista

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.